These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 3690940)

  • 1. Methoxsalen is a potent inhibitor of the metabolism of caffeine in humans.
    Mays DC; Camisa C; Cheney P; Pacula CM; Nawoot S; Gerber N
    Clin Pharmacol Ther; 1987 Dec; 42(6):621-6. PubMed ID: 3690940
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition and induction of drug biotransformation in vivo by 8-methoxypsoralen: studies of caffeine, phenytoin and hexobarbital metabolism in the rat.
    Mays DC; Nawoot S; Hilliard JB; Pacula CM; Gerber N
    J Pharmacol Exp Ther; 1987 Oct; 243(1):227-33. PubMed ID: 3668854
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of methoxsalen on the metabolism of acetaminophen in humans.
    Amouyal G; Larrey D; Letteron P; Geneve J; Labbe G; Belghiti J; Pessayre D
    Biochem Pharmacol; 1987 Jul; 36(14):2349-52. PubMed ID: 3606645
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Liver cytochrome P450 CYP1A2 is markedly inhibited by systemic but not by bath PUVA in dermatological patients.
    Tantcheva-Poór I; Servera-Llaneras M; Scharffetter-Kochanek K; Fuhr U
    Br J Dermatol; 2001 Jun; 144(6):1127-32. PubMed ID: 11422031
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of caffeine metabolism by 5-methoxypsoralen in patients with psoriasis.
    Bendriss EK; Bechtel Y; Bendriss A; Humbert PH; Paintaud G; Magnette J; Agache P; Bechtel PR
    Br J Clin Pharmacol; 1996 May; 41(5):421-4. PubMed ID: 8735685
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical pharmacokinetics of methoxsalen and other psoralens.
    de Wolff FA; Thomas TV
    Clin Pharmacokinet; 1986; 11(1):62-75. PubMed ID: 3512141
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Randomized, double-blind comparison of 1 mg/L versus 5 mg/L methoxsalen bath-PUVA therapy for chronic plaque-type psoriasis.
    Vongthongsri R; Konschitzky R; Seeber A; Treitl C; Hönigsmann H; Tanew A
    J Am Acad Dermatol; 2006 Oct; 55(4):627-31. PubMed ID: 17010742
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inactivation of cytochrome P-450 by the drug methoxsalen.
    Fouin-Fortunet H; Tinel M; Descatoire V; Letteron P; Larrey D; Geneve J; Pessayre D
    J Pharmacol Exp Ther; 1986 Jan; 236(1):237-47. PubMed ID: 3941395
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Topical methoxsalen followed immediately by long-wave UV irradiation. A preliminary report on the treatment of psoriasis.
    Danno K; Toda K; Ishida H; Horio T
    Arch Dermatol; 1982 Jul; 118(7):471-3. PubMed ID: 7092270
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of the aqueous extract from Salvia miltiorrhiza Bunge on caffeine pharmacokinetics and liver microsomal CYP1A2 activity in humans and rats.
    Wang X; Yeung JH
    J Pharm Pharmacol; 2010 Aug; 62(8):1077-83. PubMed ID: 20663043
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of cytochrome P450 2A6 increases nicotine's oral bioavailability and decreases smoking.
    Sellers EM; Kaplan HL; Tyndale RF
    Clin Pharmacol Ther; 2000 Jul; 68(1):35-43. PubMed ID: 10945314
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Single-dose methoxsalen effects on human cytochrome P-450 2A6 activity.
    Kharasch ED; Hankins DC; Taraday JK
    Drug Metab Dispos; 2000 Jan; 28(1):28-33. PubMed ID: 10611136
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition and induction of drug metabolism by psoralens: alterations in duration of sleep induced by hexobarbital and in clearance of caffeine and hexobarbital in mice.
    Apseloff G; Hilliard JB; Gerber N; Mays DC
    Xenobiotica; 1991 Nov; 21(11):1461-71. PubMed ID: 1763520
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of methoxsalen on nicotine and 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) metabolism in vivo.
    Sellers EM; Ramamoorthy Y; Zeman MV; Djordjevic MV; Tyndale RF
    Nicotine Tob Res; 2003 Dec; 5(6):891-9. PubMed ID: 14668073
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of nicotine metabolism by methoxysalen: Pharmacokinetic and pharmacological studies in mice.
    Damaj MI; Siu EC; Sellers EM; Tyndale RF; Martin BR
    J Pharmacol Exp Ther; 2007 Jan; 320(1):250-7. PubMed ID: 17021260
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Photochemotherapy of psoriasis with methoxsalen and longwave ultraviolet light (PUVA).
    Bond CA; Grant K; Boh L
    Am J Hosp Pharm; 1981 Jul; 38(7):990-5. PubMed ID: 7020414
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 5-Methoxypsoralen. A review of its effects in psoriasis and vitiligo.
    McNeely W; Goa KL
    Drugs; 1998 Oct; 56(4):667-90. PubMed ID: 9806110
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dose-dependent pharmacokinetics of caffeine in humans: relevance as a test of quantitative liver function.
    Cheng WS; Murphy TL; Smith MT; Cooksley WG; Halliday JW; Powell LW
    Clin Pharmacol Ther; 1990 Apr; 47(4):516-24. PubMed ID: 2328560
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetic and pharmacodynamics studies of nicotine after oral administration in mice: effects of methoxsalen, a CYP2A5/6 inhibitor.
    Alsharari SD; Siu EC; Tyndale RF; Damaj MI
    Nicotine Tob Res; 2014 Jan; 16(1):18-25. PubMed ID: 23884323
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Caffeine clearance and biotransformation in patients with chronic liver disease.
    Scott NR; Stambuk D; Chakraborty J; Marks V; Morgan MY
    Clin Sci (Lond); 1988 Apr; 74(4):377-84. PubMed ID: 3356110
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.